Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management
Simple Summary Obesity has been linked to several common cancers including breast,
colorectal, esophageal, kidney, gallbladder, uterine, pancreatic, and liver cancer. Obesity …
colorectal, esophageal, kidney, gallbladder, uterine, pancreatic, and liver cancer. Obesity …
Triple negative breast cancer treatment options and limitations: future outlook
O Obidiro, G Battogtokh, EO Akala - Pharmaceutics, 2023 - mdpi.com
Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER),
progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The …
progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The …
New horizons: epidemiology of obesity, diabetes mellitus, and cancer prognosis
S Harborg, KA Kjærgaard, RW Thomsen… - The Journal of …, 2024 - academic.oup.com
The global prevalence of obesity and diabetes mellitus has increased in parallel with
increasing cancer incidence, due to environmental and lifestyle factors and population …
increasing cancer incidence, due to environmental and lifestyle factors and population …
Chemotherapy and peripheral neuropathy
Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major dose-limiting side effect of
many anti-cancer agents, including taxanes, platinums, vinca alkaloids, proteasome …
many anti-cancer agents, including taxanes, platinums, vinca alkaloids, proteasome …
Inflammation and clinical decline after adjuvant chemotherapy in older adults with breast cancer: results from the Hurria Older Patients Prospective Study
J Ji, CL Sun, HJ Cohen, T Synold, H Muss… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Older breast cancer survivors are at increased risk of clinical decline after
adjuvant chemotherapy. This study aimed to evaluate whether inflammatory markers …
adjuvant chemotherapy. This study aimed to evaluate whether inflammatory markers …
Toxicity risk score and clinical decline after adjuvant chemotherapy in older breast cancer survivors
J Ji, CL Sun, HJ Cohen, HB Muss… - JNCI: Journal of the …, 2023 - academic.oup.com
Background Chemotoxicity risk scores were developed to predict grade 3-5 chemotherapy
toxicity in older women with early breast cancer. However, whether these toxicity risk scores …
toxicity in older women with early breast cancer. However, whether these toxicity risk scores …
Sex differences in neuromuscular disorders
C Vinciguerra, S Iacono, L Bevilacqua… - Mechanisms of ageing …, 2023 - Elsevier
The prevalence, onset, pathophysiology, and clinical course of many neuromuscular
disorders (NMDs) may significantly differ between males and females. Some NMDs are …
disorders (NMDs) may significantly differ between males and females. Some NMDs are …
Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin
BL Burgess, E Cho, L Honigberg - Scientific Reports, 2022 - nature.com
Management of chemotherapy-induced peripheral neuropathy (CIPN) remains a significant
challenge in the treatment of cancer. Risk mitigation for CIPN involves preemptive reduction …
challenge in the treatment of cancer. Risk mitigation for CIPN involves preemptive reduction …
[HTML][HTML] ThermoTRP channels in pain sexual dimorphism: new insights for drug intervention
D Cabañero, E Villalba-Riquelme… - Pharmacology & …, 2022 - Elsevier
Chronic pain is a major burden for the society and remains more prevalent and severe in
females. The presence of chronic pain is linked to persistent alterations in the peripheral and …
females. The presence of chronic pain is linked to persistent alterations in the peripheral and …
Patient-reported outcome measures in chemotherapy-induced peripheral neurotoxicity: defining minimal and clinically important changes
Background: Chemotherapy-induced peripheral neurotoxicity (CIPN) is a common
complication of cancer treatment that produces functional disability. Increasingly, patient …
complication of cancer treatment that produces functional disability. Increasingly, patient …